Boehringer Ingelheim
Phone: +21323344368
Fax: 213 23 34 42 13
Web: https://www.mea.boehringer-ingelheim.com
| Type | Privately held Kommanditgesellschaft with an Aktiengesellschaft as general partner |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1885 (1885) in Ingelheim am Rhein, Germany |
| Founder | Albert Boehringer |
| Headquarters | Ingelheim, Germany |
| Area served | Worldwide |
| Key people |
|
| Products | Pharmaceuticals and Animal Health |
| Revenue |  €20.6 billion (2021) |
| Operating income | €4.7 billion (2021) |
| Net income | €3.4 billion (2021) |
| Total assets | €40.6 billion (2021) |
| Total equity | €19.3 billion (2021) |
| Owner | Boehringer, Liebrecht and von Baumbach families |
| Number of employees | 52,391 (2021) |
| Website | boehringer-ingelheim.com |
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.
For detailed contact information visit location pages below.
Boehringer Ingelheim's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Boehringer Ingelheim
-
Boehringer IngelheimNot yet recruitingIdiopathic Inflammatory MyopathiesUnited States, Spain, Belgium, Germany, Italy, Taiwan, Thailand, Japan, China, France, Argentina, Australia, Serbia, Romania, Bulgaria, Hungary, Portugal, Poland, Mexico, Netherlands, South Korea, Brazil, Greece, Canada
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruitingType 2 DiabetesUnited States, India, Australia, Canada, New Zealand, Puerto Rico
-
Boehringer IngelheimRecruitingIdiopathic Pulmonary Fibrosis | Progressive Pulmonary FibrosisJapan
-
Boehringer IngelheimRecruitingExtrapulmonary Neuroendocrine Cancer (epNEC)Belgium, Germany, Australia, United States, China, Spain, Japan, Canada, United Kingdom, France, Israel, Taiwan, Netherlands, Sweden, Finland, Denmark, Hong Kong, Brazil, Austria, Portugal, Italy, Czechia, Norway, New Zealand, South Korea, Chi... and more
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruitingAcute Ischemic StrokeAustralia, China, Spain, Taiwan, Hungary, Malaysia, Thailand, Norway, India, Greece, Bulgaria, Romania, Vietnam, Argentina, Indonesia, Kazakhstan
-
Boehringer IngelheimRecruitingMelanoma | Solid TumoursUnited States, Belgium, Netherlands
-
Boehringer IngelheimRecruitingInterstitial Lung Diseases | Familial Pulmonary Fibrosis | Interstitial Lung AbnormalitiesUnited States, Belgium, Italy, Australia, Netherlands, France, Germany, United Kingdom, Japan, Spain, Canada, Argentina, South Korea
-
Boehringer IngelheimRecruitingChronic Kidney DiseaseUnited States, Belgium, Spain, Netherlands, United Kingdom, Australia, Canada, Germany, Italy, France, Singapore, Sweden, Portugal, Hungary, Poland, South Korea, Argentina, Turkey (Türkiye)